The Effect of Toremifene Treatment to the Magnetic Resonance Imaging (MRI) Findings in Premenstrual Mastalgia

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the effect of toremifene treatment to the MRI findings of the breast in women suffering from premenstrual mastalgia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Satakunta Central Hospital
• Collaborators: Tampere University; University of Tampere
• Treatments: Selective Estrogen Receptor Modulators; Toremifene

Criteria

Inclusion Criteria:

• Premenstrual mastalgia

• Age 20-45 years

• Reliable non-hormonal contraception

Exclusion Criteria:

• Pregnancy

• Breast cancer or uterine corpus cancer

• Unexplained menstrual disorders

• Serious health problems

• Hormonal contraception, including hormonal IUD trade name Mirena

• Oestrogen and/or progestin treatment

• Hysterectomy and/or oophorectomy or radiation therapy

• Artificial cardiac pacemaker/metallic prostheses